FIRDAPSE Trademark

Trademark Overview

On Saturday, September 19, 2009, a trademark application was filed for FIRDAPSE with the United States Patent and Trademark Office. The USPTO has given the FIRDAPSE trademark a serial number of 77830438. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 11, 2013. This trademark is owned by Huxley Pharmaceuticals, Inc.. The FIRDAPSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders
firdapse

General Information

Serial Number77830438
Word MarkFIRDAPSE
Filing DateSaturday, September 19, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 11, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders
Translation of Words in MarkThe wording "FIRDAPSE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 23, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuxley Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10020
Party NameHuxley Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10020

Trademark Events

Event DateEvent Description
Tuesday, November 12, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 11, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2013EXTENSION 5 GRANTED
Friday, April 5, 2013EXTENSION 5 FILED
Friday, April 5, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 5, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 5, 2013TEAS EXTENSION RECEIVED
Thursday, September 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 26, 2012EXTENSION 4 GRANTED
Monday, September 24, 2012EXTENSION 4 FILED
Monday, September 24, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 12, 2012EXTENSION 3 GRANTED
Wednesday, March 7, 2012EXTENSION 3 FILED
Wednesday, March 7, 2012TEAS EXTENSION RECEIVED
Saturday, October 1, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2011EXTENSION 2 GRANTED
Thursday, September 29, 2011EXTENSION 2 FILED
Friday, September 30, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 29, 2011TEAS EXTENSION RECEIVED
Thursday, March 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 8, 2011EXTENSION 1 GRANTED
Tuesday, March 8, 2011EXTENSION 1 FILED
Tuesday, March 8, 2011TEAS EXTENSION RECEIVED
Tuesday, October 5, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 10, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2010PUBLISHED FOR OPPOSITION
Tuesday, July 6, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 6, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 3, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 3, 2010ASSIGNED TO LIE
Wednesday, June 16, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 6, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 17, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 17, 2009NON-FINAL ACTION E-MAILED
Thursday, December 17, 2009NON-FINAL ACTION WRITTEN
Thursday, December 17, 2009ASSIGNED TO EXAMINER
Monday, December 7, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 7, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 4, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 4, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, September 23, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

firdapse cancer associated diseases disorders neuromuscular muscular preparations treatment autoimmune neurological